The potential market for the drugs is massive — more than 40 percent of adults in the U.S. are obese — and has seen explosive ...
Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...
Novo Nordisk A/S’s Ozempic helped reduce alcohol cravings in a small study, more evidence that the popular injections may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results